Dianthus Therapeutics, Inc.

Dianthus Therapeutics, Inc.

80.50
EUR
-1.00
(-1.23%)
-3.46EPS
4.28BMarket Cap
Mar 16Next Earn

Dianthus Therapeutics, Inc. Documents

FY2020 · Annual report

Form 10-K · 174 pages

Read Dianthus Therapeutics, Inc.'s results firsthand

Preview the first 2 pages of this annual report
Create a free account to start reading

Full documents are included with Professional

Q4 FY2020 documents